Moorfields building Banner overlay

Public to have their say on moving Moorfields Eye Hospital to King’s Cross

A consultation has been launched on a plan to build an eye care and research centre in central London

28 May 2019 by Selina Powell

The NHS Camden Clinical Commissioning Group (CCG) is leading a consultation from 24 May to 16 September on a plan to move Moorfields Eye Hospital to King’s Cross.

The Oriel project would build a new facility at the St Pancras Hospital site that combines eye care, research and education in ophthalmology at a single site.

The initiative is a partnership between Moorfields Eye Hospital, the University College London (UCL) Institute of Ophthalmology and Moorfields Eye Charity.

Following the end of the consultation, commissioners from 16 London and Hertfordshire CCGs and NHS Specialised Commissioning will consider whether the project should move to the next stage of planning.

If Oriel is approved, Moorfields and UCL would sell the current City Road site and buy land at St Pancras to begin construction of the facility. The facility could open to new patients by 2025–26.

Moorfields chief executive David Probert described the consultation as a “crucial milestone” in the plan to build an integrated eye care, research and education facility.

He highlighted that Moorfields is currently limited by its century-old City Road site.

“That is why we are looking at moving the hospital to a new purpose-built centre where we would be able to transform lives, turn research into new treatments faster and share our knowledge and understanding with the clinicians of tomorrow,” Mr Probert said.

Earlier public engagement had garnered responses from 1600 people across the country.

“I strongly encourage patients, staff and the wider public to use this consultation to send us their views,” Mr Probert emphasised.

Those wishing to be involved in the consultation can submit their views online.

Image credit: Metro Centric/Flickr/Creative Commons

Advertisement

Your comments

You must be logged in to join the discussion. Log in

Comments (0)

Report a comment
Close modal